(Q50500313)

14 March 2018

title

Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice. (English)

1 reference

14 March 2018

1 reference

Yusuke Sasaki

1

1 reference

14 March 2018

Mariko Noguchi-Sasaki

2

1 reference

14 March 2018

Hideyuki Yasuno

3

1 reference

14 March 2018

Keigo Yorozu

4

1 reference

14 March 2018

Yasushi Shimonaka

5

1 reference

14 March 2018

publication date

16 November 2012

1 reference

14 March 2018

International Journal of Hematology

published in

1 reference

14 March 2018

volume

96

1 reference

14 March 2018

issue

6

1 reference

14 March 2018

page(s)

692-700

1 reference

14 March 2018

Isolation and characterization of genomic and cDNA clones of human erythropoietin

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Cloning and expression of the human erythropoietin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Emerging erythropoiesis-stimulating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Iron imports. IV. Hepcidin and regulation of body iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Regulation of iron metabolism by hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Defective regulation of iron transporters leading to iron excess in the polymorphonuclear leukocytes of patients on maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Regulation of hepcidin in HepG2 and RINm5F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Development and characterization of a lung-protective method of bone marrow transplantation in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Suppression of hepcidin during anemia requires erythropoietic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on continuous erythropoietin receptor activator versus epoetin beta therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Regulation of systemic iron homeostasis: how the body responds to changes in iron demand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1217-4

Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation

21 January 2018

1 reference

12 December 2020

Purification of human erythropoietin

1 reference

12 December 2020

Hepcidin, a new iron regulatory peptide

1 reference

12 December 2020

Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis

1 reference

12 December 2020

10.1007/S12185-012-1217-4

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018